galactosamine has been researched along with Meningitis, Meningococcal, Serogroup A in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, SR; Bjune, G; Froholm, LO; Lovik, M; Oftung, F | 1 |
1 other study(ies) available for galactosamine and Meningitis, Meningococcal, Serogroup A
Article | Year |
---|---|
A mouse model utilising human transferrin to study protection against Neisseria meningitidis serogroup B induced by outer membrane vesicle vaccination.
Topics: Animals; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Vaccines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Galactosamine; Humans; Iron; Meningitis, Meningococcal; Mice; Mice, Congenic; Neisseria meningitidis; Survival Rate; Transferrin | 1999 |